Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice
(2023) In Neurochemical Research- Abstract
Sphingosine-1-phosphate (S1P) is a phosphosphingolipid with pleiotropic biological functions. S1P acts as an intracellular second messenger, as well as extracellular ligand to five G-protein coupled receptors (S1PR1-5). In the brain, S1P regulates neuronal proliferation, apoptosis, synaptic activity and neuroglia activation. Moreover, S1P metabolism alterations have been reported in neurodegenerative disorders. We have previously reported that S1PRs are present in nerve terminals, exhibiting distinct sub-synaptic localization and neuromodulation actions. Since type 2 diabetes (T2D) causes synaptic dysfunction, we hypothesized that S1P signaling is modified in nerve terminals. In this study, we determined the density of S1PRs in cortical... (More)
Sphingosine-1-phosphate (S1P) is a phosphosphingolipid with pleiotropic biological functions. S1P acts as an intracellular second messenger, as well as extracellular ligand to five G-protein coupled receptors (S1PR1-5). In the brain, S1P regulates neuronal proliferation, apoptosis, synaptic activity and neuroglia activation. Moreover, S1P metabolism alterations have been reported in neurodegenerative disorders. We have previously reported that S1PRs are present in nerve terminals, exhibiting distinct sub-synaptic localization and neuromodulation actions. Since type 2 diabetes (T2D) causes synaptic dysfunction, we hypothesized that S1P signaling is modified in nerve terminals. In this study, we determined the density of S1PRs in cortical synaptosomes from insulin-resistant Goto-Kakizaki (GK) rats and Wistar controls, and from mice fed a high-fat diet (HFD) and low-fat-fed controls. Relative to their controls, GK rats showed similar cortical S1P concentration despite higher S1P levels in plasma, yet lower density of S1PR1, S1PR2 and S1PR4 in nerve-terminal-enriched membranes. HFD-fed mice exhibited increased plasma and cortical concentrations of S1P, and decreased density of S1PR1 and S1PR4. These findings point towards altered S1P signaling in synapses of insulin resistance and diet-induced obesity models, suggesting a role of S1P signaling in T2D-associated synaptic dysfunction.
(Less)
- author
- Skoug, Cecilia LU ; Erdogan, Hüseyin ; Vanherle, Lotte LU ; Vieira, João P.P. ; Matthes, Frank LU ; Eliasson, Lena LU ; Meissner, Anja LU and Duarte, João M.N. LU
- organization
-
- MultiPark: Multidisciplinary research focused on Parkinson´s disease
- EXODIAB: Excellence of Diabetes Research in Sweden
- Diabetes and Brain Function (research group)
- Vascular Biology (research group)
- Cardiovascular Research - Translational Studies (research group)
- Department of Clinical Sciences, Malmö
- Faculty of Medicine
- Diabetes - Islet Cell Exocytosis (research group)
- WCMM-Wallenberg Centre for Molecular Medicine
- Department Office of Experimental Medical Science
- Department of Experimental Medical Science
- publishing date
- 2023-10-04
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Diabetes, Neuromodulation, Obesity, Sphingosine, Synaptosomes
- in
- Neurochemical Research
- publisher
- Springer
- external identifiers
-
- pmid:37794263
- scopus:85173946510
- ISSN
- 0364-3190
- DOI
- 10.1007/s11064-023-04033-4
- language
- English
- LU publication?
- yes
- id
- e35a3dd2-6f29-4398-a4b2-b6d5fe707617
- date added to LUP
- 2023-12-18 13:12:42
- date last changed
- 2024-04-17 01:18:05
@article{e35a3dd2-6f29-4398-a4b2-b6d5fe707617, abstract = {{<p>Sphingosine-1-phosphate (S1P) is a phosphosphingolipid with pleiotropic biological functions. S1P acts as an intracellular second messenger, as well as extracellular ligand to five G-protein coupled receptors (S1PR1-5). In the brain, S1P regulates neuronal proliferation, apoptosis, synaptic activity and neuroglia activation. Moreover, S1P metabolism alterations have been reported in neurodegenerative disorders. We have previously reported that S1PRs are present in nerve terminals, exhibiting distinct sub-synaptic localization and neuromodulation actions. Since type 2 diabetes (T2D) causes synaptic dysfunction, we hypothesized that S1P signaling is modified in nerve terminals. In this study, we determined the density of S1PRs in cortical synaptosomes from insulin-resistant Goto-Kakizaki (GK) rats and Wistar controls, and from mice fed a high-fat diet (HFD) and low-fat-fed controls. Relative to their controls, GK rats showed similar cortical S1P concentration despite higher S1P levels in plasma, yet lower density of S1PR1, S1PR2 and S1PR4 in nerve-terminal-enriched membranes. HFD-fed mice exhibited increased plasma and cortical concentrations of S1P, and decreased density of S1PR1 and S1PR4. These findings point towards altered S1P signaling in synapses of insulin resistance and diet-induced obesity models, suggesting a role of S1P signaling in T2D-associated synaptic dysfunction.</p>}}, author = {{Skoug, Cecilia and Erdogan, Hüseyin and Vanherle, Lotte and Vieira, João P.P. and Matthes, Frank and Eliasson, Lena and Meissner, Anja and Duarte, João M.N.}}, issn = {{0364-3190}}, keywords = {{Diabetes; Neuromodulation; Obesity; Sphingosine; Synaptosomes}}, language = {{eng}}, month = {{10}}, publisher = {{Springer}}, series = {{Neurochemical Research}}, title = {{Density of Sphingosine-1-Phosphate Receptors Is Altered in Cortical Nerve-Terminals of Insulin-Resistant Goto-Kakizaki Rats and Diet-Induced Obese Mice}}, url = {{http://dx.doi.org/10.1007/s11064-023-04033-4}}, doi = {{10.1007/s11064-023-04033-4}}, year = {{2023}}, }